TWC
CTIC

TD Waterhouse Canada’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

TD Waterhouse Canada’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-45
Closed -$109 – 1910
2021
Q4 		$109 Buy
+45
New +$110 ﹤0.01% 1722

Other funds holding CTIC

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TD Waterhouse Canada's CTIC Position: Q1 2022 in Review

TD Waterhouse Canada sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2022, closing a stake of 45 shares — an estimated $109 sold.

TD Waterhouse Canada first reported a position in CTIC in Q4 2021 and held it in 1 quarter. The position peaked at $109 in Q4 2021. 92 funds tracked by Wall St. Rank hold CTIC as of Q1 2022.

  • TD Waterhouse Canada reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2022 after selling out during the quarter.
  • TD Waterhouse Canada sold 45 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2022, an estimated $109.
  • TD Waterhouse Canada first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2021 and held it in 1 quarter.
  • TD Waterhouse Canada's CTI BioPharma Corp. (DE) Common Stock position peaked at $109 in Q4 2021.
  • 92 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2022.

Based on TD Waterhouse Canada's 13F filing for Q1 2022, filed 13 Nov 2023.